Rasagiline
RxNorm 134748
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 134748 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Rasagiline.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing rasagiline (medicinal product)
(Atom ID: 9262139)
INPrescribable
Ingredient (IN):
Rasagiline
(Atom ID: 2385966)
PTPrescribable
Designated preferred name (PT):
Rasagiline
(Atom ID: 2385179)
FNPrescribable
Full form of descriptor (FN):
Rasagiline (substance)
(Atom ID: 2385182)
PTPrescribable
Designated preferred name (PT):
Rasagiline-containing product
(Atom ID: 10820137)
Patient Education
Rasagiline
Rasagiline is used alone or in combination with another medication to treat the symptoms of Parkinson's disease (a slowly progressing disease of the nervous system causing a fixed face without expression, tremor at rest, slowing of movements, walking with shuffling steps, stooped posture and muscle weakness). Rasagiline is in a class of medications called monoamine oxidase (MAO) type B inhibitors. It works by increasing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.